Literature DB >> 27190369

Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy.

Nils Lachmann1, Constanze Schönemann1, Nadim El-Awar2, Matthew Everly3, Klemens Budde4, Paul I Terasaki3, Johannes Waiser4.   

Abstract

BACKGROUND: A considerable proportion of patients awaiting kidney transplantation is immunized by previous transplantation(s). We investigated how allograft nephrectomy (Nx) and withdrawal of maintenance immunosuppression (WD-MIS) in patients with a failed renal allograft contribute to allosensitization.
METHODS: HLA antibodies (HLAabs) were analyzed before and after Nx and/or WD-MIS using a single antigen bead assay. Patients were grouped as follows: (A) Nx and concomitant WD-MIS (n = 28), (B) Nx (n = 14) and (C) WD-MIS (n = 12). In a subgroup of patients, the epitope specificity of HLAabs was determined by adsorption and elution of sera with recombinant single HLA allele-expressing cell lines.
RESULTS: Following Nx and/or WD-MIS, HLAabs were detectable in 100, 100 and 92% of patients in Groups A, B and C, respectively. In patients of all groups, de novo donor-specific HLAabs (DSAs) were found. After Nx, an increase in the breadth [percent panel reactive antibody (%PRA)] and mean fluorescence intensity of class I HLAabs was predominant. In contrast, an increase of class II HLAabs prevailed following WD-MIS. Experimental analysis of the epitope specificities revealed that 64% of the class I HLAabs classically denoted as non-DSA were donor epitope-specific HLAabs (DESA).
CONCLUSIONS: Both Nx and WD-MIS contribute to alloimmunization with differing patterns concerning class I and II HLAabs. Nx preferentially increased class I HLAabs and most of the observed class I HLAabs were DESA. Considering that class I, but not class II, HLA molecules are constitutively expressed, our results support the hypothesis that the increase of HLAabs following Nx might have been caused by removal of the adsorbing donor tissue (sponge hypothesis).
© The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  HLA antibodies; allograft nephrectomy; epitope; renal transplantation

Mesh:

Substances:

Year:  2016        PMID: 27190369     DOI: 10.1093/ndt/gfw041

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  Transplant nephrectomy after graft failure: is it so risky? Impact on morbidity, mortality and alloimmunization.

Authors:  Y Chowaniec; F Luyckx; G Karam; P Glemain; J Dantal; J Rigaud; J Branchereau
Journal:  Int Urol Nephrol       Date:  2018-08-17       Impact factor: 2.370

Review 2.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

Review 3.  The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies.

Authors:  Edward J Filippone; John L Farber
Journal:  J Immunol Res       Date:  2016-12-14       Impact factor: 4.818

Review 4.  Graft nephrectomy in children.

Authors:  Benedict L Phillips; Chris J Callaghan
Journal:  Pediatr Nephrol       Date:  2017-06-19       Impact factor: 3.714

5.  The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant.

Authors:  Ailish M S A Nimmo; Sophie McIntyre; David M Turner; Lorna K Henderson; Richard K Battle
Journal:  Transplant Direct       Date:  2018-11-23

6.  Pearls and Pitfalls in Pediatric Kidney Transplantation After 5 Decades.

Authors:  Loes Oomen; Charlotte Bootsma-Robroeks; Elisabeth Cornelissen; Liesbeth de Wall; Wout Feitz
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.569

7.  Kidney re-transplantation after living donor graft nephrectomy due to de novo chromophobe renal cell carcinoma: A case report.

Authors:  Hui Wang; Wen-Li Song; Wen-Juan Cai; Gang Feng; Ying-Xin Fu
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

Review 8.  Management of chronic renal allograft dysfunction and when to re-transplant.

Authors:  Richard J Baker; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2018-07-23       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.